12-57225466-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_007224.4(NXPH4):c.646C>A(p.Leu216Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,447,350 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_007224.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NXPH4 | NM_007224.4 | c.646C>A | p.Leu216Ile | missense_variant | 2/2 | ENST00000349394.6 | NP_009155.1 | |
NXPH4 | XM_017018747.2 | c.401-209C>A | intron_variant | XP_016874236.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NXPH4 | ENST00000349394.6 | c.646C>A | p.Leu216Ile | missense_variant | 2/2 | 1 | NM_007224.4 | ENSP00000333593.6 | ||
NXPH4 | ENST00000556415.1 | n.*773C>A | non_coding_transcript_exon_variant | 3/3 | 2 | ENSP00000452288.1 | ||||
NXPH4 | ENST00000556415.1 | n.*773C>A | 3_prime_UTR_variant | 3/3 | 2 | ENSP00000452288.1 | ||||
NXPH4 | ENST00000555154.1 | n.*47C>A | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000465 AC: 1AN: 214904Hom.: 0 AF XY: 0.00000838 AC XY: 1AN XY: 119372
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1447350Hom.: 0 Cov.: 50 AF XY: 0.00000278 AC XY: 2AN XY: 719638
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 16, 2024 | The c.646C>A (p.L216I) alteration is located in exon 2 (coding exon 2) of the NXPH4 gene. This alteration results from a C to A substitution at nucleotide position 646, causing the leucine (L) at amino acid position 216 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at